Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1995-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.39.7.1522PMID 7492097PMCID PMC162774
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing

  1994cited by this paper
• Inhibitory activity on DNA gyrase and intracellular accumulation of quinolones: structure-activity relationship of Q-35 analogs.

  1994cited by this paper
• Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus

  1994cited by this paper
• Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones

  1994cited by this paper
• Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones

  1992cited by this paper
• In vitro antibacterial activity of Q-35, a new fluoroquinolone

  1992cited by this paper
• Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis

  1991cited by this paper
• Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus

  1991cited by this paper
• Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus

  1991cited by this paper
• A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus

  1991cited by this paper
• Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones

  1990cited by this paper
• In vitro activity of AT-4140 against clinical bacterial isolates

  1989cited by this paper
• Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital

  1989cited by this paper
• Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones

  1989cited by this paper
• In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone

  1988cited by this paper
• Bactericidal mechanisms of ofloxacin.

  1988cited by this paper
• Bactrecidal mechanisms of ofloxacin

  1988cited by this paper

• Phototoxicity of Quinolones and Fluoroquinolones: A Mechanistic Review About Photophysical and Photochemical Pathways

  2025cites this paper
• Halogenated Antimicrobial Agents to Combat Drug-Resistant Pathogens

  2023cites this paper
• Preparation, Characterization, and Properties of Inclusion Complexes of Balofloxacin with Cyclodextrins

  2019cites this paper
• Efficacy of some synthesized thiazoles against dermatophytes.

  2013cites this paper
• The Future of the Quinolones

  2012cites this paper
• Investigating the fluoroquinolone-topoisomerase interaction by use of novel fluoroquinolone and quinazoline analogs

  2011cites this paper
• Effect of N-1/C-8 Ring Fusion and C-7 Ring Structure on Fluoroquinolone Lethality

  2010cites this paper
• Use of Gyrase Resistance Mutants To Guide Selection of 8-Methoxy-Quinazoline-2,4-Diones

  2008cites this paper
• Mutant Selection Window Hypothesis: A Framework for Anti-mutant Dosing of Antimicrobial Agents

  2008cites this paper
• Susceptibility Testing of Clinical Isolates of Pseudomonas aeruginosa to Levofloxacin, Moxifloxacin, and Gatifloxacin as a Guide to Treating Pseudomonas Ocular Infections

  2006cites this paper
• Entwicklung zellulärer und molekularbiologischer Testsysteme zur Bestimmung der Aktivität von Fluorchinolonen auf Typ II-Topoisomerasen am Beispiel von Pradofloxacin - einem neuen C8-Cyanofluorchinolon

  2005cites this paper
• In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model.

  2004cites this paper
• Contribution of the 8-Methoxy Group to the Activity of Gatifloxacin against Type II Topoisomerases of Streptococcus pneumoniae

  2003cites this paper
• Activities of Mutant Prevention Concentration-Targeted Moxifloxacin and Levofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model

  2003cites this paper
• Contribution of the C-8-Methoxy Group of Gatifloxacin to Inhibition of Type II Topoisomerases of Staphylococcus aureus

  2002cites this paper
• Contributions of the 8-Methoxy Group of Gatifloxacin to Resistance Selectivity, Target Preference, and Antibacterial Activity against Streptococcus pneumoniae

  2001cites this paper
• [In vitro antimycobacterial activities of a new quinolone, balofloxacin].

  2001cites this paper
• Propensity of Fluoroquinolones with Different Moieties at Position 8 to Cause Resistance Development in Clinical Isolates of Streptococcus pneumoniae

  2001cites this paper
• Enhancement of Fluoroquinolone Activity by C-8 Halogen and Methoxy Moieties: Action against a Gyrase Resistance Mutant of Mycobacterium smegmatis and a Gyrase-Topoisomerase IV Double Mutant of Staphylococcus aureus

  2001cites this paper
• Chemistry and Mechanism of Action of the Quinolone Antibacterials

  2000cites this paper
• Quinolonas: Aspectos generales sobre su estructura y clasificación

  2000cites this paper
• The Quinolones: Prospects

  2000cites this paper
• Gatifloxacin Activity against Quinolone-Resistant Gyrase: Allele-Specific Enhancement of Bacteriostatic and Bactericidal Activities by the C-8-Methoxy Group

  1999cites this paper
• Fluoroquinolone Action against Clinical Isolates ofMycobacterium tuberculosis: Effects of a C-8 Methoxyl Group on Survival in Liquid Media and in Human Macrophages

  1999cites this paper
• Fluoroquinolone Action against Mycobacteria: Effects of C-8 Substituents on Growth, Survival, and Resistance

  1998cites this paper
• Analysis of recent antimicrobial agents in human biological fluids by high-performance liquid chromatography.

  1998cites this paper
• Killing of Staphylococcus aureus by C-8-Methoxy Fluoroquinolones

  1998cites this paper
• DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.

  1997cites this paper
• Fluoroquinolone antibacterials: SAR, mechanism of action, resistance, and clinical aspects

  1996cites this paper